Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

被引:652
作者
Pardi, Norbert [1 ]
Hogan, Michael J. [1 ]
Pelc, Rebecca S. [2 ]
Muramatsu, Hiromi [1 ]
Andersen, Hanne [3 ]
DeMaso, Christina R. [2 ]
Dowd, Kimberly A. [2 ]
Sutherland, Laura L. [4 ]
Scearce, Richard M. [4 ]
Parks, Robert [4 ]
Wagner, Wendeline [3 ]
Granados, Alex [3 ]
Greenhouse, Jack [3 ]
Walker, Michelle [3 ]
Willis, Elinor
Yu, Jae-Sung [4 ]
McGee, Charles E. [4 ]
Sempowski, Gregory D. [4 ]
Mui, Barbara L. [6 ]
Tam, Ying K. [6 ]
Huang, Yan-Jang [7 ,8 ]
Vanlandingham, Dana [7 ,8 ]
Holmes, Veronica M. [1 ]
Balachandran, Harikrishnan [9 ]
Sahu, Sujata [9 ]
Lifton, Michelle [9 ]
Higgs, Stephen [7 ,8 ]
Hensley, Scott E. [5 ]
Madden, Thomas D. [6 ]
Hope, Michael J. [6 ]
Kariko, Katalin [10 ]
Santra, Sampa [9 ]
Graham, Barney S. [11 ]
Lewis, Mark G. [3 ]
Pierson, Theodore C. [2 ]
Haynes, Barton F. [4 ]
Weissman, Drew [1 ]
机构
[1] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Bioqual Inc, Rockville, MD 20850 USA
[4] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA
[5] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada
[7] Kansas State Univ, Coll Vet Med, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA
[8] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA
[9] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[10] BioNTech RNA Pharmaceut, Goldgrube 12, D-55131 Mainz, Germany
[11] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
关键词
LIPID NANOPARTICLES; INFECTION; VACCINES; PSEUDOURIDINE; THERAPEUTICS; SPECIFICITY; EXPRESSION; IMMUNITY; VECTORS; THERAPY;
D O I
10.1038/nature21428
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults(1). There are no ZIKV-specific treatments or preventatives. Therefore, the development of a safe and effective vaccine is a high priority. Messenger RNA (mRNA) has emerged as a versatile and highly effective platform to deliver vaccine antigens and therapeutic proteins(2,3). Here we demonstrate that a single low-dose intradermal immunization with lipid-nanoparticle-encapsulated nucleoside-modified mRNA (mRNA-LNP) encoding the pre-membrane and envelope glycoproteins of a strain from the ZIKV outbreak in 2013 elicited potent and durable neutralizing antibody responses in mice and non-human primates. Immunization with 30 mu g of nucleoside-modified ZIKV mRNA-LNP protected mice against ZIKV challenges at 2 weeks or 5 months after vaccination, and a single dose of 50 mu g was sufficient to protect non-human primates against a challenge at 5 weeks after vaccination. These data demonstrate that nucleoside-modified mRNA-LNP elicits rapid and durable protective immunity and therefore represents a new and promising vaccine candidate for the global fight against ZIKV.
引用
收藏
页码:248 / +
页数:12
相关论文
共 31 条
  • [1] Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
    Abbink, Peter
    Larocca, Rafael A.
    De La Barrera, Rafael A.
    Bricault, Christine A.
    Moseley, Edward T.
    Boyd, Michael
    Kirilova, Marinela
    Li, Zhenfeng
    Ng'ang'a, David
    Nanayakkara, Ovini
    Nityanandam, Ramya
    Mercado, Noe B.
    Borducchi, Erica N.
    Agarwal, Arshi
    Brinkman, Amanda L.
    Cabral, Crystal
    Chandrashekar, Abishek
    Giglio, Patricia B.
    Jetton, David
    Jimenez, Jessica
    Lee, Benjamin C.
    Mojta, Shanell
    Molloy, Katherine
    Shetty, Mayuri
    Neubauer, George H.
    Stephenson, Kathryn E.
    Peron, Jean Pierre S.
    Zanotto, Paolo M. de A.
    Misamore, Johnathan
    Finneyfrock, Brad
    Lewis, Mark G.
    Alter, Galit
    Modjarrad, Kayvon
    Jarman, Richard G.
    Eckels, Kenneth H.
    Michael, Nelson L.
    Thomas, Stephen J.
    Barouch, Dan H.
    [J]. SCIENCE, 2016, 353 (6304) : 1129 - 1132
  • [2] Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors
    Abbink, Peter
    Maxfield, Lori F.
    Ng'ang'a, David
    Borducchi, Erica N.
    Iampietro, M. Justin
    Bricault, Christine A.
    Teigler, Jeffrey E.
    Blackmore, Stephen
    Parenteau, Lily
    Wagh, Kshitij
    Handley, Scott A.
    Zhao, Guoyan
    Virgin, Herbert W.
    Korber, Bette
    Barouch, Dan H.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (03) : 1512 - 1522
  • [3] N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
    Andries, Oliwia
    Mc Cafferty, Sean
    De Smedt, Stefaan C.
    Weiss, Ron
    Sanders, Niek N.
    Kitada, Tasuku
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 217 : 337 - 344
  • [4] Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013
    Baronti, Cecile
    Piorkowski, Geraldine
    Charrel, Remi N.
    Boubis, Laetitia
    Leparc-Goffart, Isabelle
    de Lamballerie, Xavier
    [J]. GENOME ANNOUNCEMENTS, 2014, 2 (03)
  • [5] Current status and future prospects of yellow fever vaccines
    Beck, Andrew S.
    Barrett, Alan D. T.
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (11) : 1479 - 1492
  • [6] ZIKA VIRUS .1. ISOLATIONS AND SEROLOGICAL SPECIFICITY
    DICK, GWA
    KITCHEN, SF
    HADDOW, AJ
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1952, 46 (05) : 509 - 520
  • [7] Rapid development of a DNA vaccine for Zika virus
    Dowd, Kimberly A.
    Ko, Sung-Youl
    Morabito, Kaitlyn M.
    Yang, Eun Sung
    Pelc, Rebecca S.
    DeMaso, Christina R.
    Castilho, Leda R.
    Abbink, Peter
    Boyd, Michael
    Nityanandam, Ramya
    Gordon, David N.
    Gallagher, John Robert
    Chen, Xuejun
    Todd, John-Paul
    Tsybovsky, Yaroslav
    Harris, Audray
    Huang, Yan-Jang S.
    Higgs, Stephen
    Vanlandingham, Dana L.
    Andersen, Hanne
    Lewis, Mark G.
    De La Barrera, Rafael
    Eckels, Kenneth H.
    Jarman, Richard G.
    Nason, Martha C.
    Barouch, Dan H.
    Roederer, Mario
    Kong, Wing-Pui
    Mascola, John R.
    Pierson, Theodore C.
    Graham, Barney S.
    [J]. SCIENCE, 2016, 354 (6309) : 237 - 240
  • [8] Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
    Dowd, Kimberly A.
    DeMaso, Christina R.
    Pelc, Rebecca S.
    Speer, Scott D.
    Smith, Alexander R. Y.
    Goo, Leslie
    Platt, Derek J.
    Mascola, John R.
    Graham, Barney S.
    Mulligan, Mark J.
    Diamond, Michael S.
    Ledgerwood, Julie E.
    Pierson, Theodore C.
    [J]. CELL REPORTS, 2016, 16 (06): : 1485 - 1491
  • [9] A rhesus macaque model of Asian-lineage Zika virus infection
    Dudley, Dawn M.
    Aliota, Matthew T.
    Mohr, Emma L.
    Weiler, Andrea M.
    Lehrer-Brey, Gabrielle
    Weisgrau, Kim L.
    Mohns, Mariel S.
    Breitbach, Meghan E.
    Rasheed, Mustafa N.
    Newman, Christina M.
    Gellerup, Dane D.
    Moncla, Louise H.
    Post, Jennifer
    Schultz-Darken, Nancy
    Schotzko, Michele L.
    Hayes, Jennifer M.
    Eudailey, Josh A.
    Moody, M. Anthony
    Permar, Sallie R.
    O'Connor, Shelby L.
    Rakasz, Eva G.
    Simmons, Heather A.
    Capuano, Saverio
    Golos, Thaddeus G.
    Osorio, Jorge E.
    Friedrich, Thomas C.
    O'Connor, David H.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [10] Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
    Guy, Bruno
    Jackson, Nicholas
    [J]. NATURE REVIEWS MICROBIOLOGY, 2016, 14 (01) : 45 - 54